The Ring of Fire
@theringoffire·1.4M subscribers·27K videos
FDA Warns That Popular Arthritis Drug Linked To Blood Clots And Death
Posted
September 2, 2019
Views
9,440
Likes
552
Comments
80
Engagement
September 2, 2019
9,440
552
80
6.69%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
You’re on September 2, 2019. Earlier episodes are to the left, later ones to the right — the row keeps loading as you go. Click any card to open it.
Sep 2, 20197:11Now PlayingSign up for Top Class Actions' FREE weekly newsletter
A new boxed Xeljanz FDA warning for blood clots and death may be relevant to consumers taking the drug for ulcerative colitis. Xeljanz is a small molecule medication used to treat psoriatic arthritis and rheumatoid arthritis. According to Verywellhealth, the drug works by inhibiting pathways in the cells that play a role in inflammation. Although the drug is often used to treat arthritis, it is also used in the treatment of ulcerative colitis. Ring of Fire’s Farron Cousins discusses this with Scott Hardy from Top Class Actions.
Become a member today!
Support us by becoming a monthly patron on Patreon, and help keep progressive media alive!
Spread the word! LIKE and SHARE this video or leave a comment to help direct attention to the stories that matter. And SUBSCRIBE to stay connected with Ring of Fire's video content!
Support Ring of Fire by subscribing to our YouTube channel
Be sociable! Follow us on:
Follow more of our stories at
Subscribe to our podcast
#rof #trofire #theringoffire #progressivenews
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
